3D-Printed nose models could boost sinus rinse results
NCT ID NCT06118554
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a 3D-printed replica of a person's own nose can help them position their head better when using steroid nasal rinses. 200 adults with chronic sinusitis will use a daily steroid rinse for 8 weeks, with some getting the 3D model to guide their head position. The goal is to see if this leads to less congestion and better quality of life.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- mometasone nasal irrigation
- What this could lead to
- If it works, this could give people with chronic sinusitis a simple, non-surgical way to get more relief from their steroid rinses.
- What could go wrong
- This is a small, early study testing a teaching tool, not a new drug. The 3D model may not actually improve symptoms, and results may not apply to everyone with sinusitis.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 200 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2021
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Chronic rhinosinusitis without nasal polyps (CRSsNP) or Chronic rhinosinusitis with nasal polyps (CRSwNP). Exclusion Criteria: * Patients with significant nasal polyps (as determined by a clinician) were excluded upfront due to the unlikeness of irrigation penetration regardless of the head position. Patients with significant atopy, cystic fibrosis, granulomatosis with polyangiitis or other connective tissue disorder, and current pregnancy were also excluded.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic rhinosinusitis with nasal polyps are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
The Ohio State University Eye and Ear Institue
RECRUITINGColumbus, Ohio, 43212, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an antibody injection shrink nasal polyps?
- Can a biologic drug plus office polyp removal beat either alone for stubborn nasal polyps?
- A biologic shot may rewire nasal polyps for years of relief
- Can a biologic drug ease the burden of severe nasal polyps?
- Can a drug that calms inflammation ease chronic sinusitis?
- Can a new drug shrink nasal polyps and restore smell?